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Enterobacter microorganisms cause important bacterial infections in humans. Recently,
carbapenem resistant isolates carrying the blaKPC gene were described and their
clonal transmission in different nosocomial outbreaks reported. In this study, the relative
numbers of Enterobacter species, their antimicrobial susceptibility along 3 years of
observation and the identification ability of the two most common MALDI-TOF platforms
were evaluated. A clustering analysis was performed to identify changes in the microbial
population within the nosocomial environment. Enterobacter were identified using two
platforms (MALDI-TOF Biotyper and VITEK MS). Antimicrobial susceptibility was tested
by Vitek2 Compact and MIC50 and MIC90 was evaluated using GraphPad software.
Clustering analysis was performed by MALDI-TOF and a dendrogram was built with
both platforms and compared. The most frequent species isolated were Enterobacter
cloacae and Enterobacter aerogenes with a gradual increase of Enterobacter asburiae
in 2017. MALDI-TOF platforms showed a very good sensitivity and specificity except
for E. asburiae identification that was reliable only by MALDI-TOF MS Biotyper. An
increase of resistance for Enterobacter, confirmed by the isolation of extended spectrum
beta-lactamase (ESBL) strains and the emergence of E. cloacae multidrug-resistant
(MDR) and carbapenem resistant strains, was observed. A clonal route of transmission
involving general surgery and geriatric wards was evidenced as previously described
for Klebsiella pneumoniae MDR strains in the same nosocomial setting. These data
represent an important source of information about the spreading of Enterobacter in the
nosocomial environment.
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INTRODUCTION
Enterobacter species are gram-negative bacilli belonging to the family of Enterobacteriaceae
and to the “ESKAPE” pathogens including Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter
species. This group of pathogens is the cause of important bacterial infections in humans
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(Boucher et al., 2009; Rice, 2010). Enterobacter cloacae
and Enterobacter aerogenes represent the most common
Enterobacter species, even if other species such as Enterobacter
asburiae have been identified as emergent pathogens causing
severe infections (Brenner et al., 1986; Stewart and Quirk, 2001;
Koth et al., 2012).
Enterobacter are intrinsically resistant to some antimicrobials,
ampicillin and I and II generations cephalosporins, showing
high ability to acquire resistance to most recent drugs,
as cephalosporins of III and IV generations, carbapenems
and aminoglycoside (Muytjens and van der Ros-van de
Repe, 1986; Leibovici et al., 1992). Recently, an increasing
prevalence of multidrug-resistant (MDR) Enterobacter strains
has been observed and in many cases nosocomial strains
acquired carbapenemases as blaNDM-1 and blaKPC limiting the
availability of appropriate antimicrobial treatments (Pottumarthy
et al., 2003; Deshpande et al., 2006; Blanco et al., 2013).
Moreover, these strains are frequently isolated in course of
bloodstream infections and severe local infection as pneumonia,
especially in critically ill patients (Fridkin, 2001; Marchaim et al.,
2008; Castanheira et al., 2011). Given the presence of these
two concomitant important factors, this group of pathogens
is progressively receiving more attention in clinical practice
for the challenge it poses today both to public health and to
the management of the spread of infections within hospital
environments (Hargreaves et al., 2015; Sidjabat et al., 2015; Zeng
et al., 2016). The first Enterobacter strain carrying blaKPC gene
was described in a septic patient in the year 2001 (Hossain
et al., 2004). Since this first identification, sporadic cases as
well as several outbreaks caused by resistant Enterobacter strains
have been described worldwide (Bratu et al., 2005; Haraoui
et al., 2013; Kiedrowski et al., 2014; Gomez-Simmonds et al.,
2016). In recent surveillance studies on carbapenem resistant
gram-negative strains, the isolates were represented primarily by
K. pneumoniae and secondly by Enterobacter species carrying the
blaKPC gene (Landman et al., 2011). The clonal dissemination
of carbapenem resistant Enterobacter has been described in
different nosocomial outbreaks, raising interest in the molecular
epidemiology of these strains (Marchaim et al., 2011; Haraoui
et al., 2013; Markovska et al., 2014; Villa et al., 2014). In a recent
study, whole-genome sequencing was applied to Enterobacter
clinical isolates from the United States, South America, and the
Mediterranean region with the aim to increase knowledge on the
genetic characteristics of these emerging pathogens. The study
revealed that these strains, evolving from a unique ancestor,
follow a clonal spread and that plasmids harboring blaKPC gene
were horizontally transferred between strains (Chavda et al.,
2016).
In this study the relative numbers of Enterobacter species
and the antimicrobial susceptibility of the strains isolated along
3 years of observation from 2015 to 2017 were evaluated.
Moreover, the identification ability of the two most common
MALDI-TOF platforms used in clinical setting was compared
in a subgroup of nosocomial strains. In these strains, based on
MALDI-TOF spectra peaks, a clustering analysis was performed
to identify changes in the microbial population over time, or
under the selective pressure of the nosocomial environment.
MATERIALS AND METHODS
Bacterial Isolates and Samples
Collection
During the years 2015–2017, 445 strains of Enterobacter species
have been isolated at the University Hospital Campus Bio-
Medico of Rome, Italy. The species isolated and their relative
number have been reported in Table 1, whereas the samples
collected from the potential sites of infection has been described
in Table 2. The study was performed using sample collected for
the routine clinical diagnosis with the patient’s consent.
Bacterial Identification
Bacterial identification was performed using the MALDI-TOF
(Microflex LT, Bruker Daltonics, Germany) with the MALDI
Biotyper 3.1 software version, and the MALDI-TOF VITEK
MS-DS (bioMérieux, Marcy-l’Étoile, France), and the Saramis
software.
MALDI-TOF MS Biotyper (Bruker,
Daltonics, Germany) Identification
Bacterial colonies were grown overnight on sheep blood agar and
subjected to according to the MALDI Biotyper protocol (Bruker
Daltonics GmbH, Bremen, Germany). Each isolate was smeared
for ten times onto target slide (Bruker Daltonics GmbH, Bremen,
Germany) (Angeletti et al., 2015).
Spectra were acquired by the standard recommended method
using the Biotyper preprocessing standard method and the
Biotyper Main-Spectrum (MSP) identification standard method
(2,000 to 20,000 Da; linear positive method; laser frequency of
60 Hz). Species were identified using the MALDI Biotyper 3.1
and its standard database (Bruker Taxonomy database version
3.3.1). The software automatically acquired spectra and analyzed
them by standard pattern matching against the spectra of the
species used as reference. After comparing the unknown spectra
comparison with the reference spectra, the log scores were
reported. Values higher than 1.9 were considered reliable for the
identification at the species level whereas values ranging from
1.9 to 1.7 were required for reliable identification at the genus
level.
MALDI-TOF VITEK MS v2.0 Identification
(BioMérieux, Marcy-l’Étoile)
Strains subcultured on sheep blood agar plates (bioMérieux)
at 37◦C for 24 h were identified by the VITEK MS. Each
TABLE 1 | Enterobacter species and their relative number isolated from the year
2015 to the year 2017.
Year E. cloacae E. aerogenes E. asburiae Total
n (%) n (%) n (%) n (%)
2015 84 (56) 60 (40) 7 (4) 151 (34)
2016 92 (62) 47 (32) 9 (6) 148 (33)
2017 105 (72) 26 (18) 15 (10) 146 (32)
Total n (%) 281 (63) 133 (30) 31 (7) 445 (100)
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TABLE 2 | Source of Enterobacter isolates during the years 2015–2017: type of samples collected.
Year Blood culture Respiratory sample Ulcer or wounds Nasal/rectal swabs Urine Total
n (%) n (%) samples n (%) n (%) n (%) n (%)
2015 20 (18) 11 (7) 68 (45) 16 (10) 36 (24) 151 (34)
2016 18 (12) 11 (7) 36 (24) 35 (24) 48 (32) 148 (33)
2017 18 (12) 7 (5) 64 (44) 18 (12) 39 (27) 146 (33)
Total n (%) 56 (12) 29 (6.5) 168 (38) 69 (15.5) 123 (28) 445 (100)
isolate was smeared for six times onto the VITEK MS-DS
target slide (bioMérieux), supplied in a 48-well microscope
slide format, and divided into three acquisition groups of
16 spots each using a 1 µL disposable loop. The prepared
samples were covered with 1 µL of α-cyano-4-hydroxycinnamic
acid (CHCA) matrix solution (bioMérieux) and dried at room
temperature. The mass spectra were acquired using a VITEK
MS Axima Assurance mass spectrometer (bioMérieux). The
isolates were identified using the Advanced Spectrum Classifier
(ASC) algorithm, comparing the obtained spectra with the typical
spectra of each organism in the VITEK MS 1.1 database (which
includes more than 25,000 spectra covering 585 species). For
system calibration and internal identification control, E. coli
ATCC 8739 was used. The VITEK MS v2.0 system is equipped
with Shimadzu Axima Assurance mass spectrometer linked
to a reference database, known as Knowledge Base. During
analysis, spectra within a range of 2,000 to 20,000 Da are
recorded in linear positive mode at a laser frequency of 50 Hz
and for each analysis, laser shots at different positions within
the target well produce up to 100 mass profiles that are
summed into a single, raw mass spectrum. The spectrum is
then processed by baseline correction and peak detected. Data
are used to query the database to determine the taxonomic
identity in form of single species-level identification. The result
from the first test with the VITEK MS, which provided a
single choice at species level with ≥90% confidence, was
used.
Antimicrobial Susceptibility Test and
Antimicrobial Activity
Enterobacter antimicrobial susceptibility tests were performed
by Vitek2 Compact (bioMérieux, Marcy-l’Étoile, France) and
the resistant phenotype further confirmed with the Kirby-Bauer
method according to Clinical Laboratory Standard Institute
(CLSI) and European Committee for Antimicrobial Susceptibility
Test (EUCAST) (Gherardi et al., 2012).
The antimicrobial activity of the compounds recommended
by EUCAST has been evaluated for the most frequently isolated
species of Enterobacter (E. cloacae and E. aerogenes) by MIC50
and MIC90 determination, using GraphPad software1. The MIC50
and MIC90 have been calculated for 70 strains isolated in 2015
(44 E. cloacae and 26 E. aerogenes), for 62 strains in 2016 (45
E. cloacae and 17 E. aerogenes) and for 58 strains in 2017 (49
E. cloacae and 9 E. aerogenes).
1https://www.graphpad.com/support/faq/fitting-bacterial-growth-data-to-
determine-the-mic-and-nic/
Clustering Analysis of MALDI-TOF MS
Spectra
Spectra obtained for each isolate on MALDI-TOF MS Biotyper
was loaded on ClinProTools by spectra grouping function,
to allow grouping of all technical replicates in one biological
replicate, named Class by the software. A Class dendrogram
of all the study isolates was built using the ClinProTool
dendrogram creation standard method (with the correlation
distance measured by the average linkage algorithm) of the
Biotyper 3.1 software (Bruker Daltonics, Germany). Clusters
were consequently analyzed according to the arbitrary distance
levels from 500 to 50.
Spectra obtained for each isolate on MALDI-TOF MS VITEK
MS were compared each other by Saramis software analysis
through which a hierarchical clustering of samples could be
performed and the results represented as a dendrogram.
RESULTS
Bacterial Isolates
Four hundreds and forty-five strains of Enterobacter species have
been isolated at the University Hospital Campus Bio-Medico of
Rome, Italy, from the year 2015 to the year 2017. The number
of strains isolated in each year was constant ranging from 151
isolates in the year 2015 to 148 and 146 in the year 2016 and
2017, respectively (Table 1). The species isolated and their relative
number and percentage have been reported in Table 1. Along
the 3 years of the study, the most frequent species was E. cloacae
(63%) followed by E. aerogenes (30%) and E. asburiae (7%). The
number of E. cloacae remained constant during the years whereas
a decrease of E. aerogenes and a gradual increase of E. asburiae
was observed in the year 2017 (Table 1).
The type of samples collected from the potential sites of
infection have been reported in Table 2. The most frequent
samples of origin were ulcers or wounds (38%) followed by
urine (28%) and surveillance nasal or rectal swabs (15.5%).
Enterobacter species were isolated in blood cultures in 12% of
cases.
Enterobacter Identification by
MALDI-TOF Platforms
Enterobacter strains were identified by two MALDI-TOF
platforms and results compared, as reported in Table 1. The
MALDI-TOF Biotyper system identified at the species level all
isolate with a sensitivity of 100%. Strains were identified as
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FIGURE 1 | Antimicrobial activities in terms of MIC50 and MIC90 registered during the years 2015–2017 for Enterobacter cloacae (panel A) and Enterobacter
aerogenes (panel B) isolates. Sensitive MIC (black color); Resistant MIC (red color); Intermedius MIC (blue color). AMC = amoxicillin-clavulanate; AN = Amikacin;
CAZ = ceftazidime; CIP = ciprofloxacin; CS = colistin; CTX = Cefotaxime; FEP = Cefepime; FOS = Fosfomycin; GM = Gentamicin; IPM = Imipenem;
MEM = meropenem; SXT = Trimethroprim/Sulfamethoxazole; TZP = piperacillin-tazobactam. Numbers indicate the MICs values.
TABLE 3 | ESBL Enterobacter strains isolated from the year 2015 to the year 2017.
Year ESBL E. cloacae ESBL E. aerogenes ESBL E. asburiae Total
strains n/total (%) strains n/total (%) strains n/total (%) n/total (%)
2015 23/84 (27) 18/60 (30) 1/7 (4) 42/151 (28)
2016 20/92 (22) 16/47 (34) 2/9 (22) 38/148 (26)
2017 36/105 (34) 7/26 (27) 8/15 (53) 51/146 (35)
Total n/total (%) 79/281 (28) 41/133 (31) 11/31 (35) 131/445 (29)
E. cloacae in 281/445 (63%) of isolates, as E. aerogenes in 133/445
(30%) isolates and as E. asburiae in 31/445 (7%) isolates.
The MALDI-TOF VITEK MS system correctly identified
E. aerogenes and E. cloacae isolates except in two cases (2 strains
of E. cloacae were not identified), whereas failed to identify all
E. asburiae strains. Globally the identification at the species level
was not achieved in 33/445 isolates (7.5%) corresponding to a
sensitivity of 92.5%.
Antimicrobial Activity and Antimicrobial
Susceptibility Test
The antimicrobial activities expressed in terms of MIC50 and
MIC90 registered during the years 2015–2017 for E. cloacae and
E. aerogenes have been represented in Figure 1. Enterobacter
species are intrinsically resistant to ampicillin and cephalosporins
of I and II generation. Regarding other antimicrobials, MIC50
was sensitive for both species except in case of Cefoxitin
and trimethoprim/sulfamethoxazole. The MIC90 revealed the
resistance for both species to cephalosporins of III and IV
generation and piperacillin/tazobactam all over the 3 years
of observation. Furthermore, the emergence of resistance to
fluoroquinolones and aminoglycoside for both species was
evidenced in the year 2017 (Figure 1).
Extended Spectrum Beta-Lactamase (ESBL) Enterobacter
strains have been isolated along the 3 years of the study. A total of
131/445 (29%) isolates resulted ESBL, as reported in Table 3. The
ESBL phenotype was identified in all three species of Enterobacter
exactly in 79/281 (28%) E. cloacae, in 41/133 (31%) E. aerogenes
and in 11/31 (35%) E. asburiae (Table 3). In the year 2017, 2/105
(1.9%) E. cloacae strains resulted MDR and carbapenem resistant.
For these two strains, the carbapenem resistance was analysed
by real-time PCR (GeneXpert Carba-R Assay, Cepheid R© Inc.) for
the following blaKPC (KPC), blaNDM (NDM), blaVIM (VIM),
blaOXA-48 (OXA-48), and blaIMP-1 (IMP-1) gene sequences.
blaIMP-1 in one strain and blaVIM genes in the other, were
detected.
Clustering Analysis of MALDI-TOF MS
Spectra
The class dendrogram of all Enterobacter isolates built by the
ClinProTool dendrogram creation standard method using the
Biotyper 3.1 software (Bruker Daltonics, Germany) revealed two
major clusters (I,II) according to an arbitrary cut-off located at
the distance level of 500 (Figure 2). In each cluster, distinct
clades are evident. Cluster I, includes clades Ia and Ib further
distinguished in the sub-clades Ib1 and Ib2. The sub-clade
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FIGURE 2 | Class dendrogram of all Enterobacter isolates built by the MALDI-TOF Biotyper 3.1 software. Asterisks (∗) identify strains isolated in general surgery and
geriatric wards; the symbol § identify multidrug-resistant (MDR) strains.
Ib2 further includes the sub-clades Ib2a and Ib2b. In cluster
I all E. cloacae and E. asburiae strains are included, exactly
E. asburiae isolates form a separate group represented in the
sub-clade Ib2, whereas all E. cloacae strains are distributed in
the other clades and sub-clades of the cluster I (Figure 2).
Cluster II includes all E. aerogenes strains distributed in
two different clades (IIa and IIb). Within cluster I and II,
strains isolated in patients admitted to general surgery and
geriatric wards are located in the same clade or sub-clade
separately from strains isolated in other hospital wards. In
cluster I, the clade Ia includes only E. cloacae strains from
general surgery and geriatric wards; in clade Ib general surgery
and geriatric isolates are always grouped in the same sub-
clades (Ib1,Ib2b) and in the sub-clade Ib2b are recovered the
two MDR isolates. Interestingly, in the sub-clade Ib2a also
E. asburiae strains are all from patients admitted in these two
wards.
The class dendrogram of all Enterobacter isolates built by
VITEK MS Saramis software, showed two major clusters I and
II. Cluster I including E. cloacae strains and cluster II including
E. aerogenes strains. In cluster I and cluster II, two different sub-
clades are evident [Ia, Ib, IIa, and IIb (Figure 3)]. A distinct clade
or sub-clade for E. asburiae strains is not represented, in fact these
strains are identified as Enterobacter spp., even if these strains are
located within the cluster I, distributed within the clades Ia and
Ib including E. cloacae isolates.
In the clades Ia and Ib E. cloacae and E. asburiae isolates from
general surgery and geriatric wards are included in the same clade
or sub-clades separately from strains of others wards. In the clade
II, E. aerogenes strains are distributed in two clades IIa and IIb,
exactly strains isolated in general surgery and geriatric wards are
represented in clade IIa whereas strains from other wards are
grouped in clade IIb (Figure 3).
DISCUSSION
The study of the microbial ecology is fundamental in the era
of antimicrobial resistance. Recently, the environment has been
suggested as source and way of dissemination of resistance,
recognizing to the environmental bacteria as well as to the
different human microbiomes an important role (Martínez, 2008;
Wright, 2010; Ashbolt et al., 2013; Finley et al., 2013; Pruden et al.,
2013).
Resistant microorganism is rapidly evolving under the
selective pressure exerted in the different environment where the
microorganism is adapting.
The nosocomial setting represents a fertile environment where
microorganism can rapidly evolve acquiring mobile genetic
elements conferring antimicrobial resistance and where their
spreading is the cause of fearsome infections.
The rapid identification of bacterial strains causing
nosocomial infections, the knowledge of the resistance patterns
and of the clonal dissemination pathway in the specific
environment can represent an advantage especially in terms of
morbidity, mortality and health costs savings.
In this study, the identification of Enterobacter pathogens
circulating within the hospital setting and their antimicrobial
susceptibility along 3 years of observation from 2015 to
2017 has been evaluated to have a picture of the circulation
of these pathogens rapidly acquiring resistance to important
antibiotics such as carbapenems. To gain deep knowledge about
the circulation of these strains, a clustering analysis based
on MALDI-TOF spectra was performed and the relationship
existing between the isolates or any potential case of clonal
transmission analyzed.
Based on the results obtained we could observe that the most
frequent species isolated were E. cloacae and E. aerogenes with
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FIGURE 3 | Class dendrogram of all Enterobacter isolates built by the MALDI-TOF VITEK MS Saramis software. Asterisks (∗) identify strains isolated in general
surgery and geriatric wards; the symbol § identify multidrug-resistant (MDR) strains.
a gradual increase of E. asburiae in 2017, a species recently
recognized as cause of severe infections (Brenner et al., 1986;
Stewart and Quirk, 2001; Koth et al., 2012). The increasing
circulation of the E. asburiae strains in the year 2017 in
the nosocomial setting confirms the general increase observed
in other settings and the potential enrollment as cause of
clinically significant infections. Furthermore, the spreading of
these emerging strains in the nosocomial setting predisposed
to the rapid acquisition of antimicrobial resistance under
the selective pressure of the antimicrobial compounds use.
Noteworthy, to the consistent increase of E. asburiae strains
corresponded an increase in the ESBL resistance phenotype that
was evidenced in about 53% of the strains isolated in the year
2017.
The Enterobacter strains identification was based on
MALDI-TOF platforms, recently introduced in the routine
of the clinical microbiology laboratory for its rapidity and
cost-effectiveness (Angeletti, 2017). The identification was
simultaneously performed by the two most frequently used
MALDI-TOF platforms and their performance compared. Both
instruments showed a very good sensitivity and specificity
except for E. asburiae identification that was reliable only
using one of this, MALDI-TOF MS Biotyper. In fact in case
of MALDI-TOF VITEK MS the two species E. cloacae and
E. asburiae were grouped together and identified as a low
discrimination result. This is in line with the observation that
the ability of identification and discrimination between different
species depends on the completeness of the database used for
spectra matching after acquisition and its updating (Angeletti,
2017).
Regarding antimicrobial susceptibility expressed in term of
MIC50 and MIC90 registered during the years 2015–2017, a
raise of the MIC90 for cephalosporins of III and IV generation,
piperacillin/tazobactam, fluoroquinolones and aminoglycoside
was detected suggesting an increase of resistance for these
antimicrobials under the selective pressure of the nosocomial
environment. This was also confirmed by the isolation of
ESBL strains for all three species, E. cloacae, E. aerogenes, and
E. asburiae and by the emergence within the nosocomial setting
in the year 2017 of E. cloacae MDR and carbapenem resistant
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strains. These data are in agreement with other studies suggesting
the evidence of isolates carrying important determinants of
carbapenem resistance such as blaIMP and blaVIM (Panopoulou
et al., 2010; Sidjabat et al., 2015). These Enterobacter strains play
an important role in nosocomial infections where carbapenems
represent an important therapeutic option especially in case of
systemic severe infections (Pottumarthy et al., 2003; Deshpande
et al., 2006; Blanco et al., 2013). The rapid identification of
these strains, the antimicrobial susceptibility and the resistant
phenotype characterization together with the strict surveillance
of the MDR strains are major concerns to limit the further
spreading of these fearsome pathogens within the nosocomial
setting.
The clustering dendrograms built on the basis of the spectra
applying mathematics algorithm, showed two major clusters by
both MALDI-TOF clustering analysis. These clusters included
distinct clades or sub-clades where strains isolated from general
surgery and geriatric wards were separated from strains of
others wards. Interestingly, the clustering realized on the spectra
similarity evidenced that those strains circulating in the general
surgery and geriatrics wards where more strictly correlated than
others isolated in different wards. A potential clonal route of
transmission preferentially between these two wards could be
suggested. This clonal route of transmission is in agreement
with our previous studies performed in the same nosocomial
setting but involving other gram-negative pathogens such as
K. pneumoniae MDR strains (Angeletti et al., 2016; Cella et al.,
2017). In these studies, gram-negative MDR strains causing
nosocomial infections moved from the general surgery to the
geriatric wards and, following this route, reached other patients
in other hospital wards. The MALDI-TOF clustering applied
to the Enterobacter spp. strains causing nosocomial infections
within the same hospital setting confirmed the existence of
this preferential way of transmission for gram-negative bacteria,
probably as a consequence of the diagnostic and invasive
procedure that are commonly used in these wards.
CONCLUSION
The results of this study on Enterobacter pathogen, able to
acquire determinant of resistance as non-metallocarbapenemase
class A carbapenemase (Blanco et al., 2013; Chavda et al.,
2016) as well as K. pneumoniae, suggest that the selective
pressure existing in the nosocomial setting and the surgical or
diagnostic procedure performed could influence the microbial
ecology of the gram-negative pathogens. These findings represent
an important source of information about the spreading of
Enterobacter, an emergent pathogen for its ability to acquire
determinants of antimicrobial resistance. Preventive measures
based on active microbiological surveillance are needed to limit
the dissemination of these microorganisms and guarantee the
health status in the nosocomial environment.
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